A urology podcast, focussing on all things prostate, kidney, bladder, testis and penile cancer. Join Professor Declan Murphy and Dr Renu Eapen from Peter MacCallum Cancer Centre in Melbourne for this regular dive into the world of genitourinary (GU) Oncology and Urology. Regular guests from all over the world, from every walk of life. Find out more gucast.org
…
continue reading
The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.
…
continue reading
CancerNetwork® is excited to announce the launch of Oncology Decoded, a new podcast that will discuss scientific data and practical application in the world of oncology. Hosted by 2 leading experts in the field, Benjamin Garmezy, MD, and Manoj Bupathi, MD, MS, this podcast will cover cutting-edge topics and offer actionable insights to help improve patient outcomes.
…
continue reading

1
6: A Sneak Peek at 2025 ASCO From the GU Perspective
16:18
16:18
Play later
Play later
Lists
Like
Liked
16:18In this special episode of Oncology Decoded, hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discussed the highly anticipated 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Bupathi is the executive cochair of the Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute (SCRI) and medical on…
…
continue reading
Dr. John Sweetenham shares highlights from Day 2 of the 2025 ASCO Annual Meeting, including new data on the treatment of ER+/HER2-negative breast cancer and potentially practice-changing results for patients with cutaneous squamous cell carcinoma at high risk of recurrence. Transcript Dr. John Sweetenham: Hello, I’m Dr. John Sweetenham, your host …
…
continue reading
In the first episode of a special daily series during the 2025 ASCO Annual Meeting, Dr. John Sweetenham discusses the results of 2 studies on the treatment of advanced colorectal cancer plus an additional study exploring the association of Medicaid expansion with cancer survival outcomes. Transcript Dr. John Sweetenham: Hello, and welcome to our sp…
…
continue reading

1
Unravelling PSMA Biology | ProsTIC/PCF Global Webinar
1:27:32
1:27:32
Play later
Play later
Lists
Like
Liked
1:27:32For serious PSMA theranostics enthusiasts!!! We bring you the ninth of our collaborative PSMA webinars over the past five years, in collaboration with our team at ProsTIC and at the Prostate Cancer Foundation in the US. A truly outstanding faculty presenting today including Misha Beltran, Marty Pomper, Ed Kwan and Louise Emmett. Co-hosted by Declan…
…
continue reading

1
ASCO25 Preview: Key Research Accelerating Cancer Care
20:42
20:42
Play later
Play later
Lists
Like
Liked
20:42Dr. John Sweetenham and Dr. Erika Hamilton discuss top abstracts that will be presented at the 2025 ASCO Annual Meeting, including research on tech innovations that could shape the future of oncology. Transcript Dr. John Sweetenham: Hello, and welcome to the ASCO Daily News Podcast. I'm your host, Dr. John Sweetenham, and I'm delighted to be joined…
…
continue reading

1
Urothelial Bladder Cancer — Fourth Annual National General Medical Oncology Summit
49:01
49:01
Play later
Play later
Lists
Like
Liked
49:01Clinical investigators discuss available data guiding the management of urothelial bladder cancer. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
In the OR with the da Vinci SP robot at London Bridge Hospital
30:36
30:36
Play later
Play later
Lists
Like
Liked
30:36What is the da Vinci Single Port (SP) robot and is it any good? Is it easy to transition from the multiport robot to a single port robot? What about Retzius-sparing prostatectomy using the SP robot? GU Cast hosts Declan Murphy and Renu Eapen learn the answers to these questions and more when we visit top prostate cancer surgeons Dr Declan Cahill an…
…
continue reading

1
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
1:00:00
1:00:00
Play later
Play later
Lists
Like
Liked
1:00:00Dr Emmanuel S Antonarakis from the University of Minnesota in Minneapolis and Professor Karim Fizazi from the Institut Gustave Roussy in Villejuif, France, provide their perspectives on relevant new clinical data in prostate cancer and discuss their application to the care of patients. CME information and select publications here.…
…
continue reading

1
China reaction to EAU Prostate Cancer Guideline Update
41:52
41:52
Play later
Play later
Lists
Like
Liked
41:52Like very many countries around the world our friends in China are big fans of the EAU Guidelines, and are always tuned in when the updated Prostate Cancer Guidelines is released every year. So as part of our China Themed Episode Series, supported by our Gold Partners Bayer China, we are discussing some key updates to this year's Guideline with our…
…
continue reading

1
5: Beyond Surgery: The Evolving Landscape of Adjuvant Therapy in Kidney Cancer
33:42
33:42
Play later
Play later
Lists
Like
Liked
33:42Manojkumar Bupathi, MD, MS; and Benjamin Garmezy, MD, dove into the complexities of adjuvant therapy for kidney cancer, providing valuable insights for oncology clinicians in the latest episode of Oncology Decoded. The discussion began with a fundamental overview of adjuvant therapy, which aims to eradicate residual microscopic disease and mitigate…
…
continue reading
A bit of a break from the usual GU Oncology routine today folks! Declan was back at Guy's Hospital recently doing a talk and heard a remarkable story told by one of the Urology Fellows, Dr Joachim Jimie. A quite spectacular mid-air crisis, and some great life lessons in there also. Declan could not resist the opportunity to grab Jimie and tell the …
…
continue reading

1
Prostate Cancer — Fourth Annual National General Medical Oncology Summit
47:33
47:33
Play later
Play later
Lists
Like
Liked
47:33Clinical investigators discuss available data guiding the management of prostate cancers. CME information and select publications here.By Dr. Neil Love
…
continue reading
180 episodes later and Declan and Renu have cracked out the champagne in the GU Cast studio! Tune in for this quick pod with some reminiscing and some thank you's, especially to you our global audience!By Professor Declan Murphy & Dr Renu Eapen
…
continue reading

1
Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates
44:21
44:21
Play later
Play later
Lists
Like
Liked
44:21Dr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Optimizing Oncology Clinical Pathways at the Point of Care
27:29
27:29
Play later
Play later
Lists
Like
Liked
27:29Dr. John Sweetenham, Dr. Larry Shulman, and Dr. Rebecca Maniago discuss the integration of clinical pathways and decision support tools into the cancer center workflow, challenges to implementation at the point of care, and the promise of AI to further unlock these tools for clinicians. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham…
…
continue reading
Radiation cystitis! Now this can be a really challenging condition for urologists, and especially for patients, to manage and to live with. And we frequently struggle to get good results. It is often years and years after radiation to the pelvis when patients return with problems like bleeding, pain, incontinence, fistula etc, which can have everyt…
…
continue reading
More great highlights from the recent EAU Annual Meeting in Madrid. Declan and Renu chat with Christian Gratzke, Sima Pore]ten, Yinjie Zhu, Rod Dunn, and have a most entertaining "pit lane walk" with Ben Challacombe around the various robots in the exhibition area. GU Cast Conference Highlights are supported by our Conference Highlights Partner, Ba…
…
continue reading
Declan and Renu bring you some great highlights from the recent EAU Annual Meeting in Madrid. Hear from Laurie Klotz and Adam Kinnaird about the OPTIMUM RCT, Sarah Psutka and Laura Bukavina discuss their bladder cancer highlights, Riccardo Campi talks biomarkers, changes in practice and other highlights, and Rod van den Bergh and Eoin Dinneen debat…
…
continue reading

1
Personalizing Lung Cancer Management With ctDNA: Where We Are and Where We Are Headed
19:09
19:09
Play later
Play later
Lists
Like
Liked
19:09Dr. Vamsi Velcheti and Dr. Charu Aggarwal discuss the evolution of ctDNA as a critical tool in precision oncology and its implications for lung cancer management, including its potential role in the early-stage setting. TRANSCRIPT Dr. Vamsi Velcheti: Hello. I am Dr. Vamsi Velcheti, your guest host for the ASCO Daily News Podcast today. I am a profe…
…
continue reading

1
4: Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer
38:59
38:59
Play later
Play later
Lists
Like
Liked
38:59In the most recent episode of Oncology Decoded, co-hosts Manojkumar Bupathi, MD, MS, executive co-chair of Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute and medical oncologist with Rocky Mountain Cancer Centers specializing in solid tumors and genitourinary cancers; and Benjamin Garmezy, MD, associate director…
…
continue reading

1
Neurosaving erectile function - a new dawn for nerve-sparing prostatectomy
39:56
39:56
Play later
Play later
Lists
Like
Liked
39:56Really big prostate cancer news today with the release of very interesting results from the Neurosafe Proof trial at the EAU Annual Meeting in Madrid. Also simultaneously published in Lancet Oncology so this is a big deal!! In summary, this multi centre randomised trial from the UK demonstrates that men undergoing the Neurosafe technique (intra-ope…
…
continue reading

1
The end of the road for TRUS biopsy? Translate trial reads out
40:25
40:25
Play later
Play later
Lists
Like
Liked
40:25We are delighted to drop this pod just as the landmark TRANSLATE trial reads out at the EAU Annual Meeting in Madrid, with a simultaneous publication in Lancet Oncology. This is the world's largest trial of transrectal vs transperineal (TP) prostate biopsy, and reports that TP biopsy has superior cancer detection ability. Is this the end of the roa…
…
continue reading

1
GU Cast in Shanghai | Prostate Cancer in China in 2025
32:31
32:31
Play later
Play later
Lists
Like
Liked
32:31Declan Murphy is in the GU Cast studio in Shanghai with GU Cast China Editor, Prof Yao Zhu. We sit down with Prof Hao Zeng (West China Hospital) and Dr Ye Yan to discuss their experiences and perspectives on advancements in diagnostics like MRI and PSMA PET, the increasing use of Chinese-developed robotic surgery platforms, and the ongoing debate s…
…
continue reading

1
Meet the Quokkas!! #USANZ25 Conference Highlights
46:21
46:21
Play later
Play later
Lists
Like
Liked
46:21This week we had the great pleasure of attending the Annual Scientific Meeting of the Urological Society of Australia and New Zealand (USANZ), which took place in the beautiful city of Perth, far out on the West Coast of Australia. Not just that, but we spent a wonderful afternoon on one of Australia’s top tourist attractions, Rottnest Island. Tune…
…
continue reading

1
Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
1:58:34
1:58:34
Play later
Play later
Lists
Like
Liked
1:58:34Dr Thomas Hutson from UMC Cancer Center in Lubbock, Texas, Dr Rana McKay from UC San Diego Moores Cancer Center in California, Dr Tian Zhang from UT Southwestern Medical Center in Dallas, and moderator Dr Sumanta Kumar Pal from City of Hope Comprehensive Cancer Center in Duarte, California, discuss published data and updates from the 2025 ASCO Geni…
…
continue reading

1
The Evolving Role of Precision Surgery in Gynecologic Cancers
25:50
25:50
Play later
Play later
Lists
Like
Liked
25:50Dr. Ebony Hoskins and Dr. Andreas Obermair discuss the surgical management of gynecologic cancers, including the role of minimally invasive surgery, approaches in fertility preservation, and the nuances of surgical debulking. TRANSCRIPT Dr. Ebony Hoskins: Hello and welcome to the ASCO Daily News Podcast, I'm Dr. Ebony Hoskins. I'm a gynecologic onc…
…
continue reading

1
Urothelial Bladder Cancer and Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU)
1:57:43
1:57:43
Play later
Play later
Lists
Like
Liked
1:57:43Drs Terence Friedlander, Matthew D Galsky, Neeraj Agarwal, Andrew J Armstrong and Elisabeth I Heath discuss recent updates on available and novel treatment strategies for bladder cancer and prostate cancer. CME information and select publications here.By Research To Practice
…
continue reading

1
3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma
25:30
25:30
Play later
Play later
Lists
Like
Liked
25:30This episode of Oncology Decoded tackled the challenging landscape of non-clear cell renal cell carcinoma (nccRCC), a heterogeneous group of tumors representing about 20% to 25% of all kidney cancers. The episode provided expert insights into the diagnosis and management of this complex disease. Meet the panel discussants: Manojkumar Bupathi, MD, M…
…
continue reading

1
Biochemical recurrence | With Steve Freedland
41:24
41:24
Play later
Play later
Lists
Like
Liked
41:24A fantastic episode for urologists, radiation oncologists, and anyone interested in localised prostate cancer. Biochemical recurrence (BCR) is unfortunately all too common after surgery or radiation for prostate cancer, and today we talk with someone who has been working in BCR for more than 20 years. Dr Steve Freedland, Urologist at Cedars-Sinai i…
…
continue reading

1
Emerging Therapies in Acute Myeloid Leukemia
29:38
29:38
Play later
Play later
Lists
Like
Liked
29:38Dr. John Sweetenham and Dr. James Foran discuss the evolving treatment landscape in acute myeloid leukemia, including new targeted therapies, advances in immunotherapy, and the current role for allogeneic transplantation. TRANSCRIPT Dr. John Sweetenham: Hello, I'm Dr. John Sweetenham, the host of the ASCO Daily News Podcast. There has been steady p…
…
continue reading

1
2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
26:21
26:21
Play later
Play later
Lists
Like
Liked
26:21When treating hormone-sensitive prostate cancer (mHSPC), one question can be, when is the right time to optimize or intensify therapy? In the latest Oncology Decoded podcast, genitourinary oncologists discuss the use of radiotherapy and define oligometastatic disease including preferred treatment options. The discussion took place during the 2025 A…
…
continue reading

1
1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer
33:13
33:13
Play later
Play later
Lists
Like
Liked
33:13During the 2025 ASCO Genitourinary Cancers Symposium, Oncology Decoded held their inaugural podcast with a live filming taking place at the conference. The first episode focused on bladder cancer specifically, neoadjuvant vs adjuvant therapy options and the use of cisplatin vs carboplatin. Meet the expert panel involved in the discussion: Manojkuma…
…
continue reading

1
Fellowship fun in Australia (and some prostate cancer chat)!
25:45
25:45
Play later
Play later
Lists
Like
Liked
25:45Two great international visitors recently led to two great sets of podcast chats!! Dr Kim Chi (Vancouver), and Dr Carmen Mir (Valencia) were in Melbourne to speak at the PROSPECT Meeting (see links below). We grabbed Kim along with Prof Arun Azad (Peter MacCallum Cancer Centre, Melbourne), and Dr Louise Kostos (also Peter Mac), to overlook some hot…
…
continue reading

1
Practice-Informing Research Across GU Oncology: Highlights From GU25
28:18
28:18
Play later
Play later
Lists
Like
Liked
28:18Dr. Neeraj Agarwal and Dr. Peter Hoskin discuss key abstracts in GU cancers from the 2025 ASCO Genitourinary Cancers Symposium, including novel therapies in prostate, bladder, and kidney cancer and the impact of combination therapies on patient outcomes. TRANSCSRIPT Dr. Neeraj Agarwal: Hello, and welcome to the ASCO Daily News Podcast. I'm Dr. Neer…
…
continue reading

1
ENZA-P Big news Update: LuPSMA and enza improves overall survival
29:36
29:36
Play later
Play later
Lists
Like
Liked
29:36A breaking news podcast from ASCO GU in San Francisco! Prof Louise Emmett (St Vincent's, Sydney), has just read out the latest update from the ENZA-P trial (and simultaneous publication in Lancet Oncology), reporting that the combination of LuPSMA and enzalutamide improves overall survival when compared with enzalutamide alone, in men with poor pro…
…
continue reading

1
Therapeutic Advances Across GI Cancers: Highlights From GI25
21:13
21:13
Play later
Play later
Lists
Like
Liked
21:13Dr. Shaalan Beg and Dr. David Wang discuss key abstracts in GI cancers from the 2025 ASCO Gastrointestinal Cancers Symposium, including major advances in CRC, neoadjuvant approaches in esophageal cancer, and innovative studies on ctDNA. TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Shaalan Beg. I'm a medical …
…
continue reading

1
Future-gazing radioligand therapy in prostate cancer | With Oliver Sartor and Michael Hofman
37:27
37:27
Play later
Play later
Lists
Like
Liked
37:27Look who popped into the GU Cast studio this week for a chat about where we are going next with radioligand therapy (RLT) for prostate cancer! Professors Oliver Sartor (Mayo Clinic, Rochester) and Michael Hofman (Peter Mac, Melbourne), are two of the world's most pre-eminent experts in the world of RLT for prostate cancer. They were each respective…
…
continue reading

1
Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
19:38
19:38
Play later
Play later
Lists
Like
Liked
19:38Dr. Jasmine Sukumar and Dr. Dionisia Quiroga discuss advances in adjuvant therapy for patients with early breast cancer and BRCA1/2 mutations, including how to identify patients who should receive genetic testing and the significant survival benefits of olaparib that emerged from the OlympiA trial. TRANSCRIPT Dr. Jasmine Sukumar: Hello, I'm Dr. Jas…
…
continue reading
Dr Toni Choueiri, Chief of GU Oncology at Dana-Farber Cancer Institute (Boston, USA) returns to GU Cast with members of his team at Dana Farber Cancer Institute to discuss our favourite lists of top GU Oncology papers for 2024. Toni has posted these now legendary lists at the end of each year on Twitter/X since the start of Covid, and they have bec…
…
continue reading

1
How to Advance Cancer Care for Native Americans
18:23
18:23
Play later
Play later
Lists
Like
Liked
18:23Native American oncologist Dr. Amanda Bruegl and Dr. Noelle LoConte discuss culturally tailored interventions and the importance of community engagement to advance cancer prevention, diagnosis, and treatment for Native communities. TRANSCRIPT ASCO Daily News: Hello and welcome to the ASCO Daily News Podcast. I'm Geraldine Carroll, a reporter for th…
…
continue reading
Part 2 of our GU Cast Conference Highlights from Shanghai including discussions with Dr Stephen Freedland (Los Angeles), Dr Liang Liang (Shaanxi), Dr Andrea Necchi (Milano), Dr Xiaojie Bian (Shanghai), and Dr Hongkai Wang (Shanghai). Declan Murphy travelled to Shanghai for the 14th GU Oncology Academic Meeting hosted by Fudan University Shanghai Ca…
…
continue reading
Declan Murphy travels to Shanghai for the 14th GU Oncology Academic Meeting hosted by Fudan University Shanghai Cancer Centre, and to meet up with our GU Cast China Editor, Dr Yao Zhu. This is an excellent meeting in one of our very favourite cities, and this year Declan joins International Faculty including Dr Stephen Freedland (Los Angeles), Dr K…
…
continue reading

1
Stories of single-port surgery (and cricket)
33:58
33:58
Play later
Play later
Lists
Like
Liked
33:58Our final episode of the year! And we end with a very seasonal celebration of single-port surgery and the Boxing Day Test with Australia playing India in one of the world's most famous cricket matches. We coaxed Dr Mihir Desai (University of Southern California, Los Angeles) and A/Prof Daniel Moon (Peter Mac, Melbourne) out of the Melbourne Cricket…
…
continue reading

1
A Dummy's Guide to Metastatic Renal Cancer!!
37:49
37:49
Play later
Play later
Lists
Like
Liked
37:49Have you ever found the choice of agents in metastatic kidney cancer just a bit perplexing??! Well then this is the podcast for you! To celebrate a fantastic review paper recently published in European Urology, we chat with first author Dr Regina Barragan-Carillo (City of Hope, California), and second senior author Dr Tian Zhang (UT South-Western, …
…
continue reading

1
What Challenges Will Oncologists Face in 2025?
23:22
23:22
Play later
Play later
Lists
Like
Liked
23:22Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact of Medicare drug price negotiations, ongoing drug shortages, and the promising role of AI and telehealth in improving patient outcomes and access to clinical trials. TRANSCRIPT Dr. John Sw…
…
continue reading

1
The Sir Chris Hoy Effect | Why family history matters
29:52
29:52
Play later
Play later
Lists
Like
Liked
29:52Legendary British cyclist Sir Chris Hoy (48) recently shocked the world by announcing that he has progressive metastatic prostate cancer. His specialists have given him a 2-4 year life expectancy. The dreadful news that no prostate cancer patient wants to hear. Today, hosts Prof Declan Murphy and Dr Renu Eapen welcome their good mates A/Prof Ben Ch…
…
continue reading

1
A New Standard of Care for Cervical Cancer: Assessing the KEYNOTE-A18 Study
13:55
13:55
Play later
Play later
Lists
Like
Liked
13:55Dr. Linda Duska and Dr. Domenica Lorusso discuss the practice-changing results of the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study, which evaluated pembrolizumab plus chemoradiotherapy as treatment for previously untreated, high-risk, locally advanced cervical cancer. TRANSCRIPT Dr. Linda Duska: Hello, I'm Linda Duska, your guest host of the ASCO …
…
continue reading

1
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Prostate Cancer
57:10
57:10
Play later
Play later
Lists
Like
Liked
57:10Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer.By Research To Practice
…
continue reading

1
PLND, ARPI Switch & De-Escalation | PROSPECT Podcast part 2
37:11
37:11
Play later
Play later
Lists
Like
Liked
37:11Part 2 Highlights from a GU Cast Live Event! Dr Kim Chi (Medical Oncologist, Vancouver) and Dr Carmen Mir (Urologist, Valencia) joined the PROSPECT meeting in Melbourne to discuss high-risk prostate cancer and mHSPC, along with many experts from around Australia. On the eve of the meeting over dinner, Declan Murphy led a GU Cast-themed panel discus…
…
continue reading
What are we to make of this large RCT of extended vs standard pelvic lymph node dissection (PLND) for prostate cancer?? Despite it not meeting its primary endpoint of improving biochemical recurrence, the authors now report in European Urology that it does reduce the incidence of distant metastases 10 years later! Go figure! We chat with Dr Karim T…
…
continue reading